Noteworthy News Articles on Mental Health Topics, November 1-10, 2003
Time on Side of Abuse Victims
Christi Parsons, Chicago Tribune- 11/2/2003
By dramatically changing the way Illinois law looks at child sexual abuse and the nature
of the harm it causes, a new statute has opened the door for many more civil suits against
alleged abusers. The new law puts Illinois among the most lenient in how much time can
pass before such a suit is filed, by essentially suspending the age limit for some
accusers. The law now acknowledges the difference between unlocking a repressed memory of
abuse and actually recognizing that it was harmful, giving accusers time for both
realizations to happen before shutting the door to litigation.
It may seem a subtle nuance, but the new law's language radically
shifts the landscape for abuse victims, who experts say may take decades to realize the
consequences of what happened to them. The change means everything for adults who were
sexually abused as children, say victims and their advocates. Whereas before the new law
almost no one older than 28 had any legal recourse, now anyone of any age could
conceivably bring a lawsuit.
"It became crystal clear to me only last year that I was harmed by
this," said Ken Kaczmarz, 34, who is suing the priest who he says abused him when he
was 11 and 12 as well as other boys at a Southwest Side church. "It took me that long
to realize that my absolute distrust for authority, the anger that I have--these things
are without a doubt related to the abuse I suffered at his hands. I'm only ready now to
confront it." Before the passage of the law, Kaczmarz was well past the civil statute
of limitations to file a suit. Now, however, his lawyer can argue in court that the clock
didn't start ticking for him until last year.
Proponents of the law are worried challenges in two courtrooms in
Springfield and Chicago may render it moot. The Springfield Diocese has challenged the
civil part of the law in a case brought by an adult alleging sexual abuse while he was a
child, and a Chicago parochial school is seeking similar action in a Cook County case,
according to the law's supporters.
Many experts on child sex abuse say suffering injury at a young age
somehow creates a treacherous chasm between the knowledge of abuse and understanding of
its consequences. Those who traverse that chasm still face a difficult fight in the courts
despite the new law. Though it gives them greater standing to file suit, the law does not
make it easier to prove the abuse occurred or an accused's guilt. By inviting so many
lawsuits based on discoveries late in life, in fact, the law may even open a whole new
line of defense for the accused. Still, the legal change is being heralded by countless
survivors of abuse. Previously, people who reported years-old abuse to police or
prosecutors found the law no longer allowed authorities to file criminal charges or civil
suits.
States consider changes
Many states have begun to consider changing their laws to address the problem,
with half a dozen legislatures examining measures to extend the statutes of limitations
for lawsuits. California is in the midst of a one-year window during which anyone can
bring a claim for damages regardless of when the alleged abuse occurred. And a year ago,
Connecticut increased the age for filing suit to 48, .
Inspired by highly publicized clergy sex abuse scandals within the
Catholic Church, lawmakers in Illinois last spring passed the law clarifying and extending
the limitations on both criminal prosecution and civil claims. Previously, prosecutors
could pursue criminal charges only if an accuser was younger than 28. Gov. Rod Blagojevich
signed the measure into law in July, allowing prosecutors to file child sex abuse charges
in future cases up to 20 years after an accuser turns 18.
A second change gives all accusers more time to file civil suits as
well. Now they have 10 years after turning 18, instead of just two years. But a third
significant change effectively suspends the age limit for many accusers: It gives them
five years after they have not just recognized they had been abused but also after they
have realized the harm it caused.
Like policymakers all over the country, Illinois officials have only
recently come to this viewpoint. The prevailing attitude was reflected in a 2000 opinion
of the Illinois Supreme Court, ruling against a 32-year-old Kane County woman suing the
priest who she alleged sexually abused her as a minor. In that case, the justices said
they thought she'd waited too long to bring her suit because she had always been aware of
what had happened to her. "The plaintiff does not contend that she repressed memories
of the abuse committed by the priest," Justice Benjamin Miller wrote, "or that
she was not aware that his misconduct was harmful. Rather, the plaintiff asserts that she
did not discover until years later the full extent of the injuries she allegedly sustained
as a result of the childhood occurrences." In those circumstances, justices said, the
clock should start at the time an accuser turns 18.
But among the vast and increasingly public network of sexual abuse
survivors, that notion runs counter to what they believe about the effects of such
abuse--and about the way victims arrive at a point where they can confront their
attackers. Knowing that you were abused and realizing you were seriously harmed by it are
two different things, many advocates and experts say. "It's almost medieval, the
ignorance about the dynamic of child abuse," said Jeff Anderson, a Minneapolis based
lawyer who is filing such civil suits in Illinois and other states. "There's a
cultural denial that the most trusted people among us wouldn't do such horrible things,
and that refusal to believe there's a problem affects the victims too. Courts and
lawmakers don't understand why it is that people need more time before they can face
it."
Realization years later
Psychologically, that often stems from the fact that it takes abuse survivors
years to realize they were crime victims, some experts say. "Your age colors your
sense of what's appropriate," said Susan Phipps-Yonas, a psychologist and expert
witness who frequently testifies in sex abuse court proceedings around the country.
"You may for a long time have such distorted cognitions about what happened and, to
whatever extent the individual feels it was her fault or his fault, that complicated so
much the ability to understand that this was abuse." Survivors have to first realize
they were victims of abuse before they can come to the knowledge that the abuse harmed
them, Phipps-Yonas said. In fact, the average age of the people who join support groups
for victims of child sex abuse is high, with few members attending before age 30,
Chicago-area support group members say.
Illinois law now more clearly respects this reasoning. It also
stipulates that none of the limitation periods run while an accuser is subject to threats,
intimidation, manipulation or fraud. As a result of this change, many who were previously
ineligible to pursue civil suits are now able to file them.
Kaczmarz is among those plaintiffs. He said he remembered in 1992 that
he had been abused by a priest when he was a child, just as stories of clergy abuse began
appearing in the media. "I started thinking about my relationship with him, and all
of these episodes in his office began coming back to me," Kaczmarz said.
Desire to protect others
Before the passage of the new law, Kaczmarz would have had no recourse, and the
suit, which he filed in February, may well have been thrown out of court. Now, though,
because he contends he discovered the harm within the last five years, he has standing to
sue the priest and the religious order in court. At the very least, Kaczmarz hopes, the
public nature of the suit will help prevent the priest from being put in positions of
trust around children again.
Dozens of other potential plaintiffs are in the same position now, said
Joe Klest, a Chicago-area attorney who handles such cases and who also helped craft the
law. While the change only allows criminal charges in future cases of abuse, victims of
all ages who have discovered their injuries in the last five years can come forward in
civil court. "This changes everything for a lot of people," Klest said.
"Finally, there is something they can do about what happened to them."
The Cruelest Cure
Lauren Slater, New York Times Magazine, 11/2/2003
I'm sitting in a room with six terrified people. Outside the window we can hear the roar
of Boston's rush hour, cars sputtering at intersections, baseball fans shouting in the
streets. Out there it is loud, but in here, at the Center for Anxiety and Related
Disorders at Boston University, it is as hushed as a hospital, the faces of the patients
slick with sweat. The director of the center, the psychologist David H. Barlow, is one of
the leading researchers in the field of fear. He isn't here today, but his methods are
guiding this therapy group, which is led by two strikingly young-looking graduate
students. It seems somehow fitting that this center, the premier institution for the
treatment of anxiety, is located smack-dab in the maze of Boston's crooked and crazy
streets.
Barlow's method for treating anxiety disorders is surprisingly simple,
although its philosophical and clinical implications are anything but. He aims to reduce
anxiety not by teaching customary relaxation techniques involving calming mantras or
soothing imagery, but by doing just the opposite: forcing the patient to repeatedly face
his most dreaded situation, so that, eventually, he becomes accustomed to the sensation of
terror. Barlow claims he can rid some people of their symptoms in as little as five to
eight days. His treatment promises to be psychotherapy's ultimate fast track, but while
many clinicians praise its well-documented results, others take a dimmer view of what one
clinician calls ''torture, plain and simple.''
What critics malign as ''torture,'' Barlow calls ''exposure.'' Here's
how it works. Ben, for instance, is 31 years old; he has come to the clinic to try to rid
himself of panic attacks. His anxieties also stand in the way of his poetry writing, and
he is fearful of people criticizing his work. One of his most feared situations is giving
a public poetry reading and knowing that the audience is restless. Therefore, the patients
and I are instructed to act as bored and rude as possible while Ben, hyped up on coffee,
reads his poems aloud. ''Remember,'' says Molly Choate, one of the group leaders, ''as he
reads, cough, whisper, laugh, rustle around.'' ''That's the part I hate the most,'' says
Ben, standing at the front of the room. He knows the boredom will be faked, but this
knowledge does nothing to assuage his fear. He begins to read. After the second line of
the poem, the audience starts the exposure. A patient scrapes his fingernails over the
rough surface of his seat, and others follow on cue, coughing, peeling the tabs off cans
of Coke and slurping at the foam that wells up. A woman leans forward and whispers audibly
in another woman's ear, ''Let's get out of here.'' Ben sweats as he forces his voice to go
louder, pushing his stanzas over the background bustle. Someone snorts.
''SUD's?'' one of the group leaders shouts out, meaning, ''subjective
units of disturbance,'' a state of fear the patient gauges himself. ''Nine,'' Ben says.
The group leader seems satisfied. SUD's occur on a scale of 1 to 10. Ten is so-called
toxic anxiety. One is cool and calm. According to Barlow, an exposure is only as good as
the amount of fear it generates.''You did it,'' Choate says at the end. Ben is finished
now. And what has he demonstrated? According to the group leaders, he has demonstrated
that he is capable of withstanding cruelty, and thus he has toughened up his limbic
system. On a neurological level, he is learning, as Barlow would put it, ''to talk to his
amygdala.'' The amygdala is fear central in our brains, and Barlow's theory is that in
panic and anxiety disorders, it reacts too strongly to tricky situations. By not
collapsing, or fainting, or, most important, running away, Ben has trained his brain to
believe in its own strength. He sits down and wipes his forehead with his sleeve. ''How'd
I do?'' he asks the group. ''Great,'' everyone says in unison, though Ben looks unhappy. I
wonder if this is because no one has praised his poetry.
When it comes to treating anxiety, Barlow is by no means the only show
in town. He's surrounded by myriad practitioners, many of whom praise him, some of whom
deride him. Eva Selhub, an instructor at Harvard Medical School and the medical director
of the Mind/Body Medical Institute, says, ''Just hearing about what he does gives me the
fight-or-flight response.'' She laughs. ''We don't believe in revving up our patients. We
believe that teaching patients how to reverse the stress response through breathing
techniques is the way to go.'' Barlow, however, disagrees. ''We have found that relaxation
can retard a person's progress,'' he says, ''because the message the clinician then sends
is that it is dangerous to be anxious. And it isn't.'' Barlow, instead, gets his patients
to drink a lot of caffeine while riding a chairlift or walking over a bridge, a kind of
vaccination approach to the problem, injecting the patient with live virus until she
builds up an immune response. ''Inoculation,'' Barlow calls it.
His detractors call his inoculations superficial. Christopher
McCullough, a professor at the Professional School of Psychology in Sacramento and a
therapist in private practice, says that methods like Barlow's are ''all surface'' and
''teach the patient nothing about why they're anxious, about what the anxiety might
mean.'' This view is echoed by his naysayers -- analysts, psychodynamic psychotherapists,
psychopharmacologists -- all of whom work outside the subspecialty of behavioral therapy
and research.
But less predictable, and more interesting, are what those within the
behaviorist subspecialty have to say about Barlow's approach. Barlow is in the odd
position of being at once highly respected by academics while being, at times, criticized
by colleagues who treat patients in the trenches. ''Yes, I've heard of him,'' says
Victoria Wolfson, a psychiatrist on staff at the Boston Medical Center. ''But I think very
few patients can tolerate that adrenaline-based approach.'' Echoing this view are
cognitive behavioral clinicians like Selhub.
Barlow's supporters are not swayed by these criticisms. After all, his
success in ameliorating anxiety is by his reckoning as high as 85 percent. David Tolin,
the director of the Anxiety Disorders Center at the Institute of Living in Hartford, says:
''Barlow's program is an ideal toward which other clinicians should strive. It is the most
rigorously tested and documented treatment for anxiety. Most practitioners don't teach his
approach because the field of psychology is relatively slow to adapt to evidence-based
treatment.'' Reid Wilson, a professor of psychiatry at the University of North Carolina
School of Medicine and an ardent Barlow supporter, adds that Barlow's work hasn't
completely caught on because, as he puts it: ''We're still on the uphill climb. We haven't
had the manpower to train enough people. Only a very small number of clinicians know about
this. They don't understand that relaxation training could actually slow treatment instead
of speed it up.''
Relaxation training was founded, in part, by Joseph Wolpe, a South
African-born psychiatrist who cultivated what is called ''systematic desensitization,'' a
method whereby you gradually expose a person to his greatest fears while helping him ''go
rag doll.'' The theory beneath the technique is that if you come to associate, say,
snakes, not with heart-stopping surges of hormones but with rhythmic relaxed breathing,
then after a while, snakes may make you sleepy.
When Barlow was in graduate school, back in the 60's, he was one of
Wolpe's students. He says it gradually dawned on him and others, like Isaac Marks, a
psychiatrist at the Institute of Psychiatry at the University of London, that inducing
calm, through pills or practice, is not necessarily helpful. Barlow's core belief is this:
people aren't afraid of external things. It's all a matter of the relationship a person
has to his or her own internalized terror. And once people disarm their terror, once they
realize that they can survive it, then you have detoxified the problem and in some senses
provided a cure. It has been a long time since anyone in the soft science of psychology
has been able to claim a cure as a part of their repertory, though Barlow recognizes that
he still doesn't have enough long-term data to guarantee that his patients will never
relapse.
Barlow's treatment is not for the faint of heart. ''A good patient is a
real workhorse,'' Wilson says. ''A good patient doesn't only accept fear; he courts it,
chases it. He says: 'C'mon panic. Give me your best shot.''' Depending upon where you
stand, comments like this can sound either inappropriately sadomasochistic or in keeping
with the current popular ethic of rugged self-reliance. I ask Wilson, ''What happens if in
the process of getting someone really hyped up, a patient has a nervous breakdown
instead?'' Wilson doesn't miss a beat. ''It's never happened,'' he says. ''If they can't
take it, we don't feed them to the lions all at once. We let them go piece by piece in the
beginning, if they really need to.''
Not everyone, however, likes being fed to the lions. Pamela, a woman
who fears public speaking, has tried Barlow's method, and she says, ''All it did was make
me worse.'' While preparing for a speech, Pamela tried spinning around on her tiptoes
while panting fast in order to get her nervous system as souped up as possible. ''I
hyperventilated, drank coffee, and all it did was make me more of a wreck. I kept trying
to do this. Eventually I got to the point where I was pretty much paralyzed.'' Pamela, who
is not a patient at the center but read about Barlow in a book, decided to try his
treatment solo, while not under the care of a therapist, which Barlow and his followers do
not recommend. While it's easy to dismiss her experience on those grounds, her criticisms
seem to make intuitive sense. ''What I really dislike about treatment like that is its
assumption that we have to be strong in order to feel secure,'' she told me. ''That's what
messed me up in the first place, the assumption my parents and society have always had
that I should win and overcome.'' Pamela's solution was to totally give in. ''I
realized,'' she says, ''that my anxiety was a product of this achieving mindset, and I
decided not to push myself.'' To that end, Pamela gave up public speaking for a while.
''Who says I have to be great?'' she says. ''Who says I can't be mediocre and scared? For
me, this was the real revolution.''
Still, Barlow has success rates that match or beat other competing
nonpharmacological interventions. Most of his patients get better in 12 weeks or fewer,
and his data suggest they stay better up to two years after treatment, beyond which point
he has not yet compiled further data. As to his claim to be able to make some of his
patients symptom-free in a mere five to eight days, he offers several videotapes to make
his case. One tape follows a fearful flier prior to treatment as she purposefully
hyperventilates her way, back and forth, between Boston and New York. Some $2,500 and 124
hours' worth of treatment later, she is completely at ease. The film is grueling and
convincing.
For homework, Ben, the poet, is instructed to stand on a busy city
street and read his work to all who rush past. A woman who fears cancer to the point of
paralysis is instructed to drink three cups of coffee while watching ''Terms of
Endearment'' repeatedly. A man who can't face being in a car is told to drive down a dark
wet road at night. Jeff, a claustrophobic businessman, has the assignment of shutting
himself in a small space for as long as he can stand it. When I spoke with Jeff about his
treatment, he explained that he had decided to lock himself in the trunk of his car. The
first time, he lasted only three minutes, in an intense state of anxiety. He curled up in
a fetal position and balled his fist up near his mouth. Eventually he conditioned himself
to last up to a half-hour in the trunk. By the last time, he says, ''I was bored.''
Every one of Barlow's clients is bearing his cross with courage. And
that fact reflects his core belief: not just anxiety but all mental illness (with the
possible exception of psychosis) is ultimately a problem not of pain itself but of a
person's relationship to his pain. Barlow is currently working on taking his treatment to
those suffering from everything from depression to substance abuse. ''It's far too early
to tell if this will work,'' he says. But he has begun treating a small group of depressed
patients by teaching them to accept, and even seek out, their sadness. According to
Barlow, attempts to suppress painful emotion lie at the heart of most pathology; the
struggle involved in suppression only tightens the noose on an already vulnerable neck. So
first sit still, Barlow says. Second, begin to act exactly counter to how you feel.
(''Even the act of smiling can change our brain chemistry,'' Barlow remarks, ''so it's
definitely O.K. to force a grin.'') Third, and most controversial, court the causes of
your depression as a means of desensitizing yourself to them. ''When you fight your own
internal censors, you're giving them too much power,'' says Reid Wilson, who employs
Barlow's methods in his practice. ''You're saying they're worth the fight. Guess what?
They aren't. There are some limitations to cognitive restructuring, because it's just like
teaching relaxation. It sends the message that negative thoughts are bad, can even kill
you. We practice the provocative approach of getting a person to confront repeatedly what
they fear until they're so used to it that it ceases to mean a thing.''
I, however, am not convinced. After all, depression is precisely a
problem of meaninglessness, whereas anxiety, one might say, is a problem of excess
meaning. What good would it do to teach a melancholic patient that his thoughts are null
and void? He already believes that acutely. Furthermore, those in a state of severe
sadness would probably lack the high, hopeful motivation that characterizes Barlow's
anxiety patients. You can get a jittery, willful guy like Jeff to shut himself in his car,
but could a depressed person really find the energy to care?
At the end of 12 weeks, all but one of the patients in the group I
observed are functioning effectively. They are free to write and read poetry, fly across
the country, visit oncology wards, drive down wet roads in the middle of the night. Jeff,
who tried drugs and meditation training before finally coming in desperation to Barlow's
clinic, says: ''I'm not going to say I don't feel fear anymore. I do. But I can say that
I'm able to now live somewhat of a normal life. I can do what I want. My fear is there,
but I handle it.'' He pauses, then he says, ''I consider that a cure.'' And in its own
way, it is a cure. Barlow claims to have carved out new territory in the world of mental
health and to have moved the field of psychology and its allied professions a significant
step forward in the actual practice of helping people. If he is able to generalize
successfully from anxiety to other forms of mental distress, like depression, with the
same success rates, he will have given us something as essential as antibiotics.
For all his contributions, though, Barlow may remain a figure on the
edge of mainstream recognition, and perhaps understandably so: he's asking us to accept a
treatment that does not consist of soothing medicine in a plastic cup. He's asking people
to accept that a cure not only hurts, but that it's also terrifying, and that's not an
easy sell. It could be that Barlow has such high success rates because there's an element
of preselection going on. Perhaps only certain types are willing to tolerate his regimen,
and clinicians, after all, have to play to their crowd, a crowd in need of something
softer. We want comfort, a hand held out, while someone else -- not us -- soldiers on.
Fetal Brains Suffer Badly From Effects of Alcohol
Linda Carroll, New York Times- 11/4/2003
Thirty years ago, scientists linked prenatal alcohol exposure with a perplexing pattern of
birth defects including neurological problems, low birth weight, mental retardation and a
set of facial malformations. Up to that time, many doctors had assumed that alcohol was so
harmless that it was sometimes administered intravenously to women who were thought to be
at risk of losing their pregnancies.
But in recent decades, scientists have discovered that alcohol can be
remarkably toxic more than any other abused drug to developing fetuses. New
research with imaging techniques is helping experts uncover which parts of the developing
brain are damaged by alcohol exposure. By pinpointing the damaged areas, they are
beginning to understand the origins of the problem behaviors and learning disabilities
linked to alcohol. Scientists are also homing in on a protein important to the developing
brain that is affected by alcohol. It is possible, they say, that a medication can be
created to protect the brains of developing fetuses, even if pregnant women cannot quit
drinking.
It is not surprising that it has taken researchers so long to tease out
the link between alcohol exposure and birth defects. For one thing, the effects of alcohol
exposure seem to vary widely. Some fetuses seem to escape unscathed, even when their
mothers drink heavily, while others are severely damaged. No one knows why. "It's not
like thalidomide, where anyone who took it had an affected child," said Dr. Sandra W.
Jacobson, a professor at Wayne State School of Medicine in Detroit, referring to the
morning-sickness drug linked to birth defects in the late 1950's and early 1960's.
"There's a range with alcohol. You might get the full-blown syndrome in 4 out of 100
heavy drinkers." There are also many babies who are affected, but not severely enough
for the syndrome to be diagnosed. Some with fetal alcohol effects may appear relatively
normal but have behavioral problems and learning deficits like those with the syndrome.
Further complicating matters is the question of how much alcohol it
takes to cause harm. In the past few years, successive studies have shown an effect at
increasingly lower levels. One study, published last year, found a small but significant
effect on average in children born to women who consumed just a drink and a half a week.
"We were surprised by this," said the lead author, Dr. Nancy Day, a professor of
psychiatry at the Western Psychiatric Institute and Clinic in Pittsburgh. The women in the
study were recruited from a prenatal clinic between May 1983 and July 1985. "The
children were in the normal range of growth," Dr. Day said, "but if you compare
them to children whose mothers didn't drink at all, they weighed less, were shorter and
had smaller head circumferences."
The effect of low levels of alcohol appears to be subtle, said Dr.
James R. West, head of the department of anatomy and neurobiology at the Texas A&M
medical school. "Perhaps instead of having an I.Q. of 120, you might end up with
115," he said. "You might seem perfectly normal, but not have the motor skills
to make the high school football team."
Another factor making it difficult to tease out the impact of alcohol
is its widespread effects on the developing brain and body. "Alcohol is a dirty
drug," Dr. West added. "It affects a number of different neurotransmitters, and
all cells can take it up." Compare this with cocaine, Dr. West said, which is taken
up by only one neurotransmitter. It is also difficult to identify the effects of alcohol
because a woman's drinking habits seem to make a big difference. Experts say it matters
when a pregnant woman drinks, how often she drinks and what her pattern of drinking is:
whether she drinks small amounts daily or periodically binges. Drinking in the first
trimester can lead to facial malformations, while in the second it can interrupt nerve
formation in the brain, Dr. West said. During the third, it can kill existing neurons and
interfere with nervous system development, he added. Researchers have also determined that
babies are more likely to be affected if mothers drink in a binge pattern, like five
drinks one day rather than a single drink daily, Dr. Jacobson of Wayne State said.
Because alcohol affects so many sites in the brain, researchers have
come to believe that alcohol is far worse for the developing fetus than any other abused
drug. Dr. Jacobson's study included cocaine users who also used varying quantities of
alcohol. "We found more serious cognitive impairment in relation to alcohol than
cocaine or other drugs, including marijuana and smoking," Dr. Jacobson said. The
damage done to fetuses often has been wrongly connected to cocaine, many experts say.
"The consensus, I think, at this point is that most of the adverse effects that had
been reported due to cocaine and crack use were from alcohol use," said Dr. Kenneth
R. Warren, the director of the office of scientific affairs at the National Institute on
Alcohol Abuse and Alcoholism. "It is the leading cause of birth defects due to an
ingested environmental substance in this country."
In 1973, researchers coined the phrase fetal alcohol syndrome to
describe babies born with a certain pattern of neurologic and physiologic defects related
to alcohol exposure in utero. Early on, it was clear that exposed children were wired
differently from normal ones and that they exhibited an array of disabilities. Dr. Ann P.
Streissguth, the director of the fetal alcohol and drug unit at the University of
Washington and a professor at the medical school there, ticked off a list: "These
included attention problems, hyperactivity, learning problems particularly in
arithmetic language problems, memory problems, fine and gross motor problems, poor
impulse control, poor judgment, intellectual deficits and difficulty integrating past
experience to plan and organize future behavior."
Researchers wondered whether specific areas of the brain were being
consistently harmed by alcohol exposure in utero. Poor judgment, for example, might point
to damage to the frontal lobes. The lobes, as the control center of the brain, are
involved in planning, organizing and inhibiting inappropriate responses, the researchers
say.
Thirty years ago, the only way researchers could learn about the
effects of alcohol on the brain was to study children who died shortly after birth.
"We knew from brain autopsies that in severe cases the brains were terribly
disorganized," said Dr. Edward P. Riley, the director of the Center for Behavioral
Teratology at San Diego State University. Now, researchers use imaging techniques like
M.R.I.'s to look at the damage caused by alcohol. Several recent studies using magnetic
resonance imaging have shown damage to the corpus callosum, a band of nerve fibers that
connects the left and right sides of the brain.
A report published in 2002 compared the brain scans of adults and
children who had severe or mild alcohol-related disabilities with the scans of healthy
counterparts. The researchers found that the corpus callosa were abnormally shaped in 80
percent of those who had been exposed to alcohol in utero. Another study found that the
corpus callosum was smaller and shifted forward in children and young adults with the
syndrome. Using a technique known as diffusion tensor imaging to look closer at the corpus
callosum, researchers at Emory University have seen abnormalities in the myelin, the
substance that insulates nerve cells. When the myelin is damaged, signals do not carry as
crisply through the cells, said Dr. Claire D. Coles, director of the Fetal Alcohol Center
at the Marcus Institute and a professor of psychiatry and behavioral sciences at Emory.
Another study published in 2002 found that frontal lobe structures were
smaller in teenagers and young adults who had been exposed to alcohol prenatally. By
pinpointing which sections of the brain are most likely to be damaged by alcohol,
scientists may find a way to block its effects.
Researchers recently recognized that some of alcohol's effects were
similar to those experienced by children born with defects in genes that control L1
adhesion cells. Fetal cells that are destined to grow into the brain and nervous system
bind to one another with the help of adhesion molecules like L1, said Dr. Michael E.
Charness, an associate professor of neurology at Harvard. In laboratory experiments, Dr.
Charness and his colleagues showed that alcohol could interfere with L1's stickiness, thus
hampering crucial cell-to-cell attachments.
In an article published in The Proceedings of the National Academy of Sciences in July,
they showed that a protein, NAP, could block alcohol's effect on L1. When NAP was given to
mice exposed to alcohol, the protein appeared to stave off neurological effects. "The
idea of giving drugs to pregnant women is controversial," Dr. Charness said.
"Drugs may have their own risks." But, he said, there are areas of the world
where fetal alcohol syndrome is a huge problem. In parts of South Africa, the incidence of
the syndrome in first graders is around 4.5 percent, he said. "The rate of drinking
is high," Dr. Charness added. "And the women won't stop drinking despite
interventions. It might be reasonable to give them a drug that can prevent the more
serious effects of alcohol."
Therapist, Firm Named in Medicare Fraud Case
Chicago Tribune, 11/7/2003
The owner of a Chicago-area mental-health company and one of her therapists defrauded
the federal Medicare program of more than $1 million in a three-year period, an indictment
unsealed Thursday alleges.
Theresa Phillips, 33, of Bolingbrook, owner of Healthcare Creations,
allegedly recruited people as therapists who lacked the proper credentials to have their
work reimbursed by Medicare. Fernandos Johnson, of the Chicago area, one of the
"various unqualified individuals," also was indicted Thursday. Phillips' company
provided psychotherapy services to nursing home patients. To get paid by Medicare,
Phillips had a psychologist and a doctor sign progress reports for patients that other
therapists had seen, even when the doctor and psychologist had not seen the patients
themselves.
The indictment alleges Phillips, Johnson, and others defrauded Medicare
of about $1.3 million between 1999 and 2002 and that Phillips tried to move the money
around among various bank accounts to hide her taking it from her company. Between April
29 and July 1, 2002, they cashed checks from Medicare worth almost $48,000, according to
the indictment. The government is seeking about $1.3 million in cash and bank account
funds from Phillips, as well as two Bolingbrook homes and a 2000 Mercedes Benz.
Desperately Trying to Relate to Her Body by Cutting It
Stephen Holden, New York Times- 11/7/2003
Marina de Van as a woman obsessed with cutting her flesh. From nail biting and nose
picking to bulimia and drug taking, the list of potentially self-destructive compulsions
to which we are susceptible is virtually endless. Marina de Van's "In My Skin,"
a harrowing portrait of a 30-something woman who succumbs to an obsession with cutting her
own flesh, suggests that such extreme behavior is often a desperate attempt to
re-establish a connection with the body that has been lost. In a sterile, corporate
culture where human appetites are quantified, tamed and manipulated by market research and
where people are rewarded for functioning like automatons, it implies, uncontrollable tics
are really the anxious, protesting twitches of an oppressed animal spirit.
Esther (Ms. de Van), the film's central character, finds herself on the
fast track to disaster practically overnight after she injures a leg while stumbling
around a junk-strewn building site in the dark. Amazed afterward that she felt nothing
until she looked down and discovered she was trailing blood, she develops an intoxicated,
almost cannibalistic fascination with her own torn flesh and ability to ignore physical
pain. At the core of her compulsion is an elusive, increasingly desperate search to feel
something, anything. When one arm goes to sleep while she's in bed with her boyfriend,
Vincent (Laurent Lucas), she examines it as if it were detached from the rest of her body.
During a stressful business dinner at which she gulps too much wine too quickly, she
fantasizes that the same arm, severed at the elbow, is lying beside her plate, and she
becomes so agitated that she excuses herself and rushes to the wine cellar to carve some
sensation into the limb.
The deeper Esther sinks into a self-consuming frenzy, the less she is
able to hide her fetish from her suspicious boyfriend and her co-workers at a marketing
company where she has just been promoted to be in charge of an international jewelry
account. But her feelings of shame are no match against the force of disease that causes
them. On the way home from that business dinner, Esther goes so far as to fake a car
accident to explain her fresh self-inflicted wounds.
Because the movie looks at the world through Esther's frightened eyes,
the camera shares her voyeuristic fascination with her own torn flesh. Its refusal to
blink at Esther's self-mutilation makes the film, which opens today at the Angelika Film
Center in New York, often uncomfortable to watch. Anyone who is repulsed by images of
sharp objects puncturing flesh is advised to stay away. For the less faint of heart,
however, "In My Skin," which Ms. de Van wrote and directed, is as unrelenting an
exploration of isolation and dissociation as Roman Polanski's "Repulsion." That
dissociation is illustrated late in the film by the use of a split screen. The intensity
of its focus on Esther's loss of control ultimately forces us to identify her behavior
with whatever embarrassing tics and eccentricities we might be struggling to conceal.
Ms. de Van, who resembles a feral, gap-toothed version of the young
Leslie Caron, is at once beautiful and ugly. And as the area of her wounds expands from a
leg to an arm and eventually to her face, her fits of self-mutilation take on the
intensity of auto-erotic trances. Some of the most disturbing scenes observe Esther
digging out small pieces of her own flesh and chewing on them in a state of feverish
distraction that evokes a guilt-ridden ecstasy and the character's helpless awareness of
impending doom. In certain shots, she resembles a wild animal simultaneously attacking
itself and licking its wounds.
This remarkable debut film doesn't arrive out of nowhere. Ms. de Van
has worked with the director François Ozon. Together the two wrote "Under the
Sand" and "8 Women," and Ms. de Van also appeared in his ominous short film
"See the Sea." As a director and screenwriter as well as an actress she has the
goods.
Written (in French, with English subtitles) and directed by Marina de
Van; director of photography, Pierre Barougier; edited by Mike Fromentin; music by E.S.T.
(Esbjorn Svensson Trio); production designer, Baptiste Glaymann; produced by Laurence
Farenc; released by Wellspring. At the Angelika Film Center, Mercer and Houston Streets,
Greenwich Village. Running time: 93 minutes. This film is not rated. With Marina de Van
(Esther), Laurent Lucas (Vincent), Léa Drucker (Sandrine), Thilbault de Montalembert
(Daniel), Dominique Reymond (The Female Client) and Bernard Alane (The Male Client).
Homeless Veterans Wage a New Battle--For Respect
Ken Kusmer, Associated Press- 11/8/2003
INDIANAPOLIS - Darryl Boyd exudes strength from the shaved head crowning his
6-foot,5-inch, 235-pound Navy veteran's body to his T-shirt's image of bulging biceps
pulling a forearm free of shackles. But look more closely, and you see the shirt's
message: "Freedom from Active Addiction." Boyd speaks of a life filled with
desperation: homelessness, alcoholism, crack addiction, mental illness, rejection.
"Every time I'd get a fleeting glimpse of reality, it was depressing," Boyd
said.
Many of the estimated 500,000 homeless among the nation's 27 million
veterans share parts of that reality. More than two-thirds of homeless vets battle
addictions, according to the Department of Veterans. Affairs; nearly half contend with
mental illness. This year, they are mustering to win more respect from Washington and the
public. A federal panel on homeless veterans presented has urged more mental health
funding and improved VA services.
Veterans groups also are urging more help. Among their leaders is Chuck
Haenlein, a retired Army officer and head of the board of the National Coalition of
Homeless Veterans. He also is president of the private, nonprofit Hoosier Veterans
Assistance Foundation, which houses 127 homeless vets in houses, apartments and a detox
center in Indianapolis.
In June, the foundation created a program allowing 40 vets to stay in
four- to eight-bedroom houses as long as needed while they attend substance-abuse
counseling at nearby Roudebush VA Medical Center. Drug or alcohol abuse in a homeless
shelter typically means eviction. The new program requires drug tests, but backsliders get
sent to a treatment facility. They get the second chances they need.
Groups like Haenlein's are sprinkled across the country. The VA in
August awarded up to $8 million in per-diem payments to programs in 25 states. Surveys
show that veterans overall tend to have higher incomes, better educations and lower
poverty and jobless rates than the general population, but they also have a higher rate of
homelessness, the VA says. It estimates that about a third of homeless adults are
veterans, mostly men.
"It's not just homelessness itself. It's alcoholism. It's drug
addiction. It's mental health," said Bob Rogers, a VA social worker who helps
mentally ill homeless vets get help. Congress passed the Homeless Veterans Comprehensive
Assistance Act in December 2001. It required the VA to provide more help for homeless vets
and those at risk of becoming homeless, and to speed up their benefits claims.
The law also prompted the creation of a 17-member VA Advisory Committee
on Homeless Veterans. The panel presented its first report in July, delivering
recommendations that include increasing to $100 million the total amount the VA delivers
to local agencies serving homeless vets (the limit now is $75 million) and working with
the Pentagon to counsel personnel at risk of homelessness. Veterans groups also are taking
up the issue. The largest, the 2.8 million-member American Legion, named a task force in
January to lift the profile of homeless vets and create more programs to serve them.
Boyd enlisted in the Navy in 1982 and was a radioman on a submarine
tender. After shipmates learned he was gay, he tried kill himself with 60 pain pills. The
Navy discharged him in 1986, and Boyd worked as a barber. His mother threw him out when
his crack habit nearly cost her her home. He lived on the streets of Indianapolis for more
than a year, working as a prostitute and contracting HIV. The turning point came last
year. He moved into a mission and completed a VA drug rehab program. He found a job moving
skids of textbooks for a college and took real estate classes. Now he hopes to pass his
state realty exam and pursue a goal of buying properties to create transitional housing
for homeless veterans. Said Boyd: "I've got a plan going on here."
School for Autistic Children Sought
Mitra Kalita, Washington Post- 11/9/2003
The Fairfax County School Board is considering a proposal from parents to form a
charter school for autistic children, offering intense, one-on-one instruction in their
earliest years of schooling. The parents hope it will enable their children to go on to
traditional classrooms and normal childhoods. But school officials, expressing concern
about cost, accountability and effectiveness, are recommending that the board reject the
plan or add several conditions, including providing assurances of a balanced budget and
that organizers can provide the number of teaching hours proposed. "There are
legal issues for the county," said Thomas Brady, chief operating officer for Fairfax
County schools. "Who does this independent public school charter report to? Do they
meet state standards for special services?"
Parents, who will make a formal presentation at the board's work
session tomorrow, say they have spent years fine-tuning the idea and studying the best
ways to educate children with autism, a neurological disorder defined by problems with
communication, behavior and social interaction. The application submitted to the county is
the seventh draft of a 116-page document.
If approved, it would be the first charter school of any kind in
Northern Virginia and just one of a handful in the state. Randolph Nicklas, chairman of
the nonprofit group Parents for Autistic Children's Education (PACE), which developed the
proposal, said he was aware of three charter schools for autistic children nationwide.
Charter schools, dubbed by advocates as "public schools of
choice," operate independently of state and local regulations but are financed by the
school systems in which they are based. Fairfax school officials said the district would
incur more than a half-million dollars in start-up costs for the charter school. Nicklas
said the school would qualify for federal and foundation grants, which would defray some
of the start-up and operating expenses. Unlike many other charter schools, the one
proposed for Fairfax would teach students at several locations.
Under the PACE proposal, the charter school would enroll as many as 60
students year-round from preschool to age 12 and disburse them among a half-dozen or so
schools. One instructor would be hired for every student, and each would employ a teaching
method known as "applied behavior analysis." The method aims to make
learning less frustrating for children by providing them with questions and answers at the
same time. It also uses toys, nature and a child's surroundings to teach language and
behavior. Lessons are repeated until they are learned. The annual cost per pupil is
estimated at $40,000.
Fairfax schools use this approach to teach some autistic students, who
often learn alongside children with other disabilities. But Colleen Oppenheimer, mother of
an autistic child, said she wishes for more consistency and expertise. Her 7-year-old son,
Clifford, attends elementary school in Reston. "Every year that he's been in
Fairfax, the autism program has changed," she said. "First they were half a day.
Then they were full-day. His class size doubled. Then he was moved into a reduced
teacher-student ratio class."
Years ago, Fairfax tried a pilot program using applied behavior
analysis but dropped it because of the high cost and mixed results. Of 10 students,
two graduated to traditional kindergarten, recalled School Board member Tessie Wilson
(Braddock), who has long been an advocate of the charter school. "Does it help
every child 100 percent? No," Wilson said. "But there were the two kids where
the change in these children was nothing short of miraculous."
At a meeting Thursday night, School Board members peppered staff
members with questions about the role of the individual public schools where the
charter-school students would attend class. They worried about the school system's
liability if children don't emerge from the charter school ready for inclusion in regular
classrooms. The parents' group says the program is worth the risk. "Every
parent's hope is that their child will lose the diagnosis and look like any other typical
kid," Nicklas said.
Group Helps Victims of Abuse Break the Cycle
Anna Gorman, Los Angeles Times- 11/9/2003
Eliza's senior year in high school was filled with fear. She recalls her ex-boyfriend's
controlling her every movement, practicing martial arts on her, leaving her with bruises
and scrapes. Her grades dropped, and she quit participating in theater and soccer. Her
acceptance to UC Santa Cruz was revoked. "I missed a lot of school because I was too
scared to go," said the articulate 20-year-old, who did not want her last name used.
"I didn't know where to go or what to do."
Finally, during a doctor's visit, she learned about Break the Cycle, a
nonprofit organization that provides free and confidential legal advice, advocacy and
representation to victims of emotional and physical abuse. About 550 youths received
legal help from the group this year. A staff attorney listened to Eliza's story and then
helped her get a three-year restraining order against her ex-boyfriend.
In addition to legal services, Break the Cycle also connects the youths
with shelters and support groups, and serves as a nationwide resource center on domestic
violence. "It's not just about handing somebody a restraining order," said
Jessica Aronoff, director of programs and policy. "It's about empowering them so they
know they have rights, and so they know they can choose to take action to protect
themselves."
The organization began in Los Angeles in 1996, and recently opened
offices in New York and San Francisco. Most clients are women ages 16 to 22, and many are
either pregnant or have young children. Break the Cycle also runs a prevention program,
teaching students about dating and domestic violence and training school counselors and
law enforcement officers on how to respond. The organization received a $15,000 grant this
year from the Los Angeles Times Holiday Campaign, which raises money for nonprofits in Los
Angeles, Orange, Riverside, San Bernardino and Ventura counties.
The youths who go to Break the Cycle's Los Angeles office are
experiencing relationships in very adult ways, but don't have the experience to know what
is healthy and what is abusive, Aronoff said. Some are terrified and crying, while others
are fed up and angry. Each client has a terrible story to tell.
Abra, 18, who is pregnant with twins, said she was sexually assaulted
by the babies' father, who also bought a gun and threatened to kill her. Cynthia, 16, said
her ex-boyfriend repeatedly abused her, throwing her against a concrete wall and slamming
her against a wooden cabinet. Break the Cycle helped both young women obtain
restraining orders. In exchange for the services, the women are encouraged to give back to
Break the Cycle by writing an article for its newsletter, speaking to a school group or
creating artwork for the office.
Eliza has given back by sharing her experience in a promotional video
and speaking at a fund-raiser. Even after she got the restraining order, Eliza said,
it took a while to get her life on track and to stop blaming herself for what had
happened. Now Eliza is in her second year at the Art Institute of Los Angeles, and
is determined not to get involved in another abusive relationship. "I know what I
deserve now," she said. "I almost had to have everything taken away from me to
start fresh and rebuild. Each day, it's getting better and better."
Drugs of Psychiatric Patients Subbed Without OK
Ellen Barry, Boston Globe- 11/10/2003
A doctor at a state mental health facility changed patients' medications last year so
that they would be eligible for a study of a new psychiatric drug, violating basic
guidelines for research on human subjects and causing dangerous side effects in a
43-year-old man with schizophrenia, a state investigation has found. The Disabled Persons
Protection Commission uncovered numerous ethical violations at the Solomon Carter Fuller
Mental Health Center by Boston Medical Center physicians contracted to treat patients
there.
According to a DPPC report, patients' medications were switched without
informed consent and without a clear medical need, the changes were made more than two
months before the human-studies review boards approved the research protocol, and the
patients involved were clearly not eligible under the criteria for the study, which
specified that subjects be outpatients. One of the four patients whose medication was
switched, a man who had been stable for 10 years on the drug Clozaril, became so ill and
acutely psychotic that he spent months in and out of hospital wards. He was diagnosed with
neuroleptic malignant syndrome, a rare, sometimes lethal side effect of medication
changes, according to the commission's report.
When the man's health problems grew serious enough to discuss in a
Department of Mental Health case conference, a top state mental health official expressed
shock that there was a plan to use patients as human research subjects. "The incident
. . . was an egregious series of events that led to a patient experiencing debilitating
psychiatric and medical symptoms," wrote Clifford Robinson, Department of Mental
Health area director, in a September memorandum about the investigation. The incident
"delineated what can happen when a research project is introduced into a clinical
environment that is unprepared for it."
The DPPC is an independent state agency that investigates alleged abuse
against any disabled person in the Commonwealth. A year ago, Janssen Pharmaceutica was
preparing to introduce Risperdal Consta, a two-week injectible form of Risperdal, its drug
to treat schizophrenia. To troubleshoot its instructions for physicians switching patients
from oral Risperdal to Consta injections, Janssen asked a number of researchers -- among
them Dr. Domenic Ciraulo, Boston Medical Center's chief of psychiatry -- to test the
transition on a total of 60 adult patients who were on oral Risperdal, said Carol
Goodrich, a Janssen spokeswoman. Each site would be paid on completion of the trial,
Goodrich said. Janssen declined to reveal the amount.
Ciraulo turned to the Fuller as a site for the study, delegating
authority to its medical director, Dr. Douglas Hughes. The prospect of a clinical trial at
the Fuller promised to bring prestige to a downtown community health center that, situated
among many august research centers, "had not been an attractive place for residents
and medical students," Hughes later told investigators. "We saw the Consta study
as an opportunity."
But as they looked for eligible subjects, one doctor began asking
patients about participating in the trial. Last fall, months before review boards for
Boston University and the Department of Mental Health had approved the study, the doctor
switched four patients to oral Risperdal so they could be enrolled in the trial, the
report said. By late January, one of the four became so confused and delusional that he
was sent to the emergency room and frequently needed to be restrained. Months later, when
he returned to the Fuller, he was emotionally drained and sensitive to any antipsychotic
medication. Known among the staff as an avid and "very knowledgeable" Red Sox
fan, the patient was asked by a state investigator for a favorite player on the current
team. He mentioned Carl Yastrzemski, who retired from baseball 20 years ago, and had no
response to the names "Nomar," "Manny," or "Pedro," the
report said. The clinical trial at the Fuller was halted in February, and no patients
there ever received Consta. The other three patients switched to Risperdal suffered no ill
effects.
Changing medications for research without the patients' consent is
unethical, and it's especially questionable in a state institution, said Dr. Peter Lurie,
a medical researcher with Public Citizen's Health Research Group, which monitors research
ethics. Institutionalized patients, like prisoners, may feel pressure to become subjects,
and researchers, as well as their institutions, could benefit financially from recruiting
subjects, Lurie said. As soon as medication changes were made, the clinical trial was
effectively underway, without oversight to protect subjects' rights -- "a flagrant
violation of clinical ethics," he said. The names of doctors involved were deleted
from the commission report, but Department of Mental Health officials and Hughes
acknowledged their identities.
On Sept. 29, Hughes resigned his position as medical director of the
Fuller, explaining in a letter to center director Dr. Mary Louise White that he believed
he "shared responsibility" for the change of medication, which he ascribed to a
"failure of communication between the principal investigator and the physicians . . .
at the SCFMHC." Hughes, who was listed as one of Boston magazine's "Best
Doctors" in 2000, is now associate director of training and medical director of
outpatient services at BMC's department of psychiatry. He is a paid speaker for Janssen
Pharmaceuticals, and earned more than $30,000 in speaking fees last year, he said.
The attending physician who switched the four patients, Dr. Valentina
Jalynytchev, is still working at the Fuller, said Lester Blumberg, chief of staff at the
Department of Mental Health. Jalynytchev did not respond to requests to be interviewed for
this article, but told investigators that she believed preparing the patient to receive
Consta -- the first injectible form of a newer-generation antipsychotic -- was a
"good treatment option," made with "nothing but his best interest in
mind."
Both doctors plan to appeal the report's findings, said Ellen Berlin, a
Boston Medical Center spokeswoman. Berlin would not say whether either doctor had been
disciplined. The doctors could also be disciplined through the Massachusetts Board of
Registration in Medicine, which reviews complaints of misconduct and regulates doctors'
licenses to practice medicine. No public information is available about action in this
case, said Nancy Achin Audesse, the board's executive director.
In an interview, Hughes said Ciraulo had given him authority over the
study at the Fuller, but he had received no training in working with human subjects. The
physicians at the Fuller, he said, believed that it was permissible to switch patients'
medications so they could be eligible for the study. When staff members complained that
the switch was unethical, Hughes said, he asked Ciraulo informally whether informed
consent was necessary. "I said, `Is this OK? Is this a problem? Can we not switch
people's medications from one approved atypical antipsychotic medication to another?'
" Hughes recalled in a telephone interview last week. Ciraulo, he said, told him
doctors were free to do that.
Through Berlin, Ciraulo declined requests to be interviewed for this
article. But in the state report, Ciraulo was quoted as saying that he had "no
clinical responsibility" over Fuller psychiatrists. His attorney told the Disabled
Persons Protection Commission that the Fuller "does not allow [Ciraulo] . . . the
authority necessary to deal with situations that may be regarded as his
responsibility" as the leader of the study.Ciraulo, a well-published researcher, has
received research grant funding from Janssen Pharmaceutica, served as a Janssen
consultant, and received support from Janssen for the department of psychiatry, a Boston
University faculty disclosure report said.
Top officials of the Department of Mental Health first learned of the
study in February, during a medical staff conference to discuss patients. After the
meeting, the area medical director, Dr. David Hoffman, wrote of his shock to discover that
a trial was underway: "I was never cc'd on any of this, and I didn't know anything
about a drug study at the Fuller involving our patients as human subjects. At that point,
I began to realize how problematic this was. The medication switch from Clozaril to
Risperdal was a violation of the drug study's protocols." Within weeks,
investigations were underway at the commission, the Department of Mental Health, and
Boston Medical Center. The Consta study was terminated by the DMH's Research Review
Committee on Feb. 21.
In its review, the Department of Mental Health determined that neither
Jalynytchev nor Hughes, her supervisor, intentionally jeopardized patients. "This was
a physician who was poorly informed and poorly supervised about conducting research,"
said Blumberg, the chief of staff. "Her direct supervisor should have known, if he
didn't know." Instead, Robinson, the Department of Mental Health area director, wrote
a blistering memorandum pointing to a "major systems failure" in Boston Medical
Center's patient safeguards. Robinson also criticized the hospital's internal review,
which "failed to identify, in any material way, what went wrong, how broad the
breakdown was and what could be learned from it." The review did not address the fact
that Jalynytchev had switched the medication of four patients, not just the one who was
injured, he wrote. "The absence of a sense of remorse in any document reviewed is
another noteworthy commentary on the failure of this process to attend to the harm that
resulted," Robinson noted. Berlin, the BMC spokeswoman, did not respond to the
criticism of the internal review.
Boston Medical Center "immediately implemented" a corrective
action plan to improve aspects of patient care at the Fuller, according to a press release
from the hospital. The two institutions are discussing a range of changes to prevent a
recurrence, from appointing a liaison to oversee joint activities to eliminating all
research, the release said.
Researchers at the hospital are also being asked to undergo
recertification in the ethics of human research. An e-mail widely circulated last week
among medical center psychiatrists and psychologists announced that they will have to take
monthly quizzes on such issues as federal regulations, internal review-board policies, and
conflict of interest. The e-mail was provided to the Globe. The quizzes, which will be
graded, may be a "bureaucratic hurdle," the letter explains, but the Office of
Clinical Research sees it as "a necessary step to keep our researchers current on
clinical research information and to provide appropriate protection for the subjects who
volunteer for our studies."
Mental health officials could prohibit Boston Medical Center from
undertaking clinical trials at state facilities, Blumberg said. The episode has not
jeopardized the mental health agency's contract with the medical center, he said.
"It's been a long and positive relationship," he said. "Part of what is so
troubling about this is that it's an anomaly in our relationship with them."
Success of Addicts Doing Treatment, Not Time, Questioned
Catherine Saillant, Los Angeles Times- 11/10/2003
Two years after implementation, the jury is still very much out in Ventura County over
whether a voter-approved diversion program for nonviolent drug offenders is a success.
Under the provisions of Proposition 36, just over 4,000 county drug offenders have been
referred to drug treatment and supervision rather than being sent to jail. Of those, 280
have completed required therapy sessions and are considered drug free. But is a 7% success
rate good enough?
Yes, say the county alcohol and drug administrators who run the
$2.5-million program. It will take time to work out kinks that could be impeding a
higher number of graduates, said county Behavioral Health Director Linda Shulman in a
briefing to the Board of Supervisors on Nov. 1.Since the program got off the ground two
years ago, various agencies have been struggling with confidentiality rules and improving
communication, she said. Proposition 36, which California voters approved in
November 2000, permits first- and second-time, nonviolent offenders convicted of simple
drug possession to receive substance abuse treatment instead of incarceration.
Shulman said it is also important to recognize they are addressing a problem drug
addiction, often aggravated by alcoholism or mental illness in which relapse is
common.
While the number of graduates is relatively low, about 40% of those
referred are making progress in beating their addiction, Shulman said. "It is
working. We've had successful graduates, and we are meeting statewide averages," she
said. "It may not be working for 100% of them, but if it is working for 40% of them,
that is 40% who are no longer doing drugs and no longer are a cost to our prison
system."
However, Dist. Atty. Greg Totten and Sheriff Bob Brooks have been
openly critical. They say the diversion rules are lax and tracking of offenders is
insufficient.Administrators need to better track how many participants have been convicted
of a new criminal offense while enrolled and maintain a breakdown of the crimes they have
committed, said Chief Deputy Dist. Atty. Michael Frawley. The county also should be
reporting how many people are dropped from the program because they have used up the three
chances, or strikes, allowed under the law, Frawley said. "We have had people who
tested dirty 10 or more times before they are brought to the attention of the court,"
he said. "They are out in the streets and using a lot." Brooks suggested that
recent spikes in property crimes in Ventura could be attributed to the new law. But
Shulman and others dispute that, saying the correlation is unclear.
Statewide, counties have responded favorably to the effects of
Proposition 36, said Steve Szalay, executive director of the California State Assn. of
Counties. Counties are treating more people than expected and are discovering that many
have additional problems, such as mental illness or lack of job training, that stand in
the way of recovery, Szalay said. But overall, drug offenders are getting the
treatment they need and are staying out of jail, he said. "We think it's been a
success," he said. "Given the structure put forth in the initiative, it's done
quite well."
Though the initiative mandates that counties provide drug treatment,
state funding is available only through 2006. UCLA researchers are conducting a five-year
evaluation of the program, including potential cost savings.
In Ventura County, nonviolent drug offenders are referred to a
Proposition 36 courtroom. Each morning, a legal team meets with Judge Barry Klopfer to
determine the best course of treatment for each defendant. The team is made up of a
prosecutor, public defender, probation official and treatment provider. Klopfer, who
helped Ventura County start its own drug court several years ago, said the collaborative
approach helps him decide who really is interested in getting help and what kind of
services they need. "That part has been a tremendous success," Klopfer said.
"We are much more able to make use of what has been learned about the individual and
their performance, to differentiate between those struggling but working on it and those
who simply are not interested."
The problem with the law is that it treats everyone as though they are
equally motivated to change, the judge said. That means that even if it is clear
that someone is only going through the motions, Klopfer must still give the offender three
chances before terminating probation. Some mechanisms to measure an offender's readiness
to kick addiction would help keep out those who really don't want treatment, Klopfer said.
And in an era of tight budgets, that might make sense, he said. "I want to provide
treatment where the taxpayers, the citizens, are going to get the most for their
money," the judge said. "If you want to call that cherry-picking, go ahead. But
we make those judgments in our lives every day."
Shannon Corpuz, 35, agreed that motivation is crucial. Corpuz, a
Ventura painter, told Ventura County supervisors that, when he was first referred to the
program for abusing methamphetamine, he didn't think he had anything to learn. After
completing 12 months of treatment, he was drug-free for the first time in 12 years and has
remained so for two years, he said. |